Riskpilot← Back to searchSign inGet full accessGHP Diabetes Care AB
ABDissolvedOrg 5593620791GöteborgActivities of holding companies · NACE 6420Est. 20220 employees
Revenue 2023
SEK 0
EBITDA margin
—
+99% vs 2022
Equity ratio
-11971.7%
Financial strength
Net profit 2023
SEK -41K
+100% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -42K | +99% |
| Net profit | SEK -41K | +100% |
| Total assets | SEK 60K | -99% |
| Equity | SEK -7,2M | -1% |
| Employees | 0 | — |
Legal name
GHP Diabetes Care AB
Org number
5593620791
Legal form
Aktiebolag
NACE code
6420 · Activities of holding companies
Founded
24 januari 2022
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva diabetesvård, förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Göteborg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −8 240 | −42 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −8 240 | −42 |
| Net financials | — | 1 |
| Profit before tax | −8 240 | −41 |
| Tax | −0 | −0 |
| Net profit | −8 240 | −41 |
| Item | 2022 | 2023 |
|---|---|---|
| Total assets | 7 094 | 60 |
| Equity | −7 142 | −7 183 |
| Long-term debt | 0 | 0 |
| Short-term debt | 14 235 | 7 242 |
| Total debt | 14 235 | 7 242 |
EBITDA margin
-4200000.0%
This company
15.8%
Market median
-26582378% vs market
20222023
Equity ratio
-11971.7%
This company
38.2%
Market median
-31440% vs market
20222023
Return on equity
-4100000.0%
This company
18.4%
Market median
-22282709% vs market
20222023
Net profit margin
-4100000.0%
This company
8.1%
Market median
-50617384% vs market
20222023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222023
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20222023
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LE Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
MS Chief Auditor | Chief Auditor | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2022 | |
| Former (5) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Chairman | 2022 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GHP Diabetes Care AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linda Elisabeth Sallander | Chief Auditor | 0 companies |
| Mikael Sjölander | Chief Auditor | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Bo Marcus Nord | Board of Directors | 0 companies |
| Wendy Lissette Fahlgren | Board of Directors | 0 companies |
| Dag Olov Andersson Tilk | Chairman | 0 companies |
| Robert Richard Ball | Board of Directors | 0 companies |
| Daniel Robert Öhman | Board of Directors | 0 companies |
| Nils Henrik Wilhelm Brehmer | Deputy Board Member | 0 companies |
| Karl Johan Cagmo | Deputy Board Member | 0 companies |